SCHEMBL2855840

SCHEMBL2855840

CCC(CC)CC(CC)CC(C(=O)O)C(CC(CC)CC(CC)CC)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 3/20 0.37
SLC1A2 P43004 3/20 0.37
SLC1A1 P43005 3/20 0.37
TDP1 Q9NUW8 2/20 0.36
CHRM1 P11229 1/20 0.33
AKR1A1 P14550 1/20 0.33
CHRM3 P20309 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
CA2 P00918 1/20 0.33
MAPK1 P28482 1/20 0.33
ACE P12821 1/20 0.33
RNPEP Q9H4A4 1/20 0.31
SLC7A5 Q01650 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19690591 0.95 SLC1A3 (0.39) SLC1A3SLC1A2SLC1A1TDP1CHRM1
SCHEMBL27958019 0.81 PIN1 (0.37) SLC1A3SLC1A2SLC1A1TDP1
SCHEMBL18489653 0.76 MAPT (0.38) SLC1A3SLC1A2SLC1A1
Calcium SCHEMBL31454403 0.76 CA2 (0.50) SLC1A3SLC1A2SLC1A1TDP1CA2
SCHEMBL24045951 0.76 TDP1 (0.43) SLC1A3SLC1A2SLC1A1TDP1CHRM1
SCHEMBL1008665 0.76 SLC1A3 (0.41) SLC1A3SLC1A2SLC1A1TDP1CHRM1
SCHEMBL12950308 0.72 SLC1A2 (0.60) SLC1A3SLC1A2SLC1A1TDP1CHRM1
SCHEMBL2696819 0.72 NAALAD2 (0.46) SLC1A3SLC1A2SLC1A1HDAC1HDAC2
SCHEMBL1604267 0.72 TDP1 (0.50) SLC1A3SLC1A2SLC1A1TDP1CHRM1
SCHEMBL13761133 0.72 TDP1 (0.50) SLC1A3SLC1A2SLC1A1TDP1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11840508-B2 Catalyst system for olefin polymerization and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2023-12-12 US disclosed
EP-4006061-A1 CATALYST SYSTEM FOR OLEFIN POLYMERIZATION AND USE THEREOF China Petroleum & Chemical Corporation (CN) 2022-06-01 EP disclosed
US-8822366-B2 Solid titanium catalyst component, catalyst for olefin polymerization and process for polymerizing olefin MITSUI CHEMICALS, INC. (JP) 2014-09-02 US disclosed
EP-2206731-B1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, AND OLEFIN POLYMERIZATION METHOD MITSUI CHEMICALS INC (JP) 2013-08-28 EP disclosed
US-20100227991-A1 SOLID TITANIUM CATALYST COMPONENT, CATALIST FOR OLEFIN POLYMERIZATION AND PROCESS FOR POLYMERIZING OLEFIN MITSUI CHEMICALS, INC. (JP) 2010-09-09 US disclosed
EP-2206731-A1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, AND OLEFIN POLYMERIZATION METHOD Mitsui Chemicals, Inc. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11840508-B2 Catalyst system for olefin polymerization and use thereof SQSTM1, SAMM50, HPD SLC1A3 4693/4885SLC1A2 4790/4885SLC1A1 4844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.